NCT07027852

Brief Summary

Study Description: My Lung Health Coach (MLHC) is a virtual COPD education and self-management support program delivered through one-on-one sessions with a Certified Respiratory Educator (CRE) over 12 weeks. It includes six sessions that cover essential COPD topics such as: Basic COPD knowledge, Smoking cessation, Medications (inhalers, oxygen), Physical activity, Mental health and wellness, Vaccinations, Symptom self-management, Nutrition, Travel, and Long-term planning (including end-of-life care). The investigators have also developed a companion app to MLHC integrated into the electronic patient record that patients can access through their EPIC MyHealth app on the participants phones, tablets, or desktops. This study will evaluate the feasibility and effectiveness of MLHC and the companion app.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
1mo left

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Jan 2025Jun 2026

First Submitted

Initial submission to the registry

January 13, 2025

Completed
2 days until next milestone

Study Start

First participant enrolled

January 15, 2025

Completed
5 months until next milestone

First Posted

Study publicly available on registry

June 19, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 5, 2026

Expected
Last Updated

June 19, 2025

Status Verified

June 1, 2025

Enrollment Period

9 months

First QC Date

January 13, 2025

Last Update Submit

June 16, 2025

Conditions

Keywords

COPDTelehealthTelemonitoringRespiratory

Outcome Measures

Primary Outcomes (12)

  • Feasibility (system use): Number of patients who started program over total offered, over one year.

    Number of patients who started program over total offered for one year.

    1 year

  • Feasibility (system use): Number of patients who completed program over total started, over one year.

    Number of patients who completed program over total started for one year.

    1 year

  • Feasibility (system use): Number of providers who referred patients to the program over total Number of providers, over approximately one year.

    Number of providers who referred patients to the program over total Number of providers, over approximately one year.

    1 year

  • Effectiveness (clinical outcomes): Number of COPD-related outpatient visits

    Number of COPD-related outpatient visits

    outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up.

  • Effectiveness (clinical outcomes): Hospital admissions

    Hospital admissions

    outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up.

  • Effectiveness (clinical outcomes): ED visits

    ED visits

    outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up.

  • Effectiveness (clinical outcomes): ICU admissions (at baseline will be over the previous 12 months)

    ICU admissions (at baseline will be over the previous 12 months)

    outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up.

  • Effectiveness (clinical outcomes): COPD severity as measured by the COPD assessment test (CAT)

    COPD severity as measured by the COPD assessment test (CAT)

    outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up.

  • Effectiveness (clinical outcomes): Medication

    Medication

    outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up.

  • Effectiveness (clinical outcomes): Referrals: pulmonary rehab

    Referrals: pulmonary rehab

    outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up.

  • Effectiveness (clinical outcomes): Referrals: smoking cessation counseling

    Referrals: smoking cessation counseling

    outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up.

  • Effectiveness (clinical outcomes): Referrals: specialist care

    Referrals: specialist care

    outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up.

Study Arms (1)

Single Arm Behavioral

EXPERIMENTAL

Study Description: My Lung Health Coach (MLHC) is a virtual COPD education and self-management support program delivered by a Certified Respiratory Educator (CRE) over 12 weeks. The investigators have also developed a companion app to MLHC integrated into the electronic patient record that patients can access through their EPIC MyHealth app. This study will evaluate the feasibility and effectiveness of MLHC and the companion app.

Behavioral: My Lung Health Coach

Interventions

Virtual education and self-management program with companion application

Single Arm Behavioral

Eligibility Criteria

Age40 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must be deemed to have capacity to provide informed consent;
  • Must sign and date the informed consent form;
  • Stated willingness to comply with all study procedures;
  • Be diagnosed with COPD as per a WCH Respirologist
  • Be 40 years or older
  • Be a current or ex-smoker
  • Preferred but not required: have a history of at least 1 COPD exacerbation (requiring prednisone or antibiotic use, or an urgent healthcare visit of any kind) in the previous 12 months

You may not qualify if:

  • Experienced a COPD exacerbation in the 4 previous weeks to study enrollment
  • Co-diagnosis of asthma by a WCH Respirologist
  • Significant co-morbidities that could interfere with program participation or terminal illness
  • Unwilling to download and use the Epic Care Companion app and has a unsuitable mobile device to do this
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Womens College Hospital

Toronto, Ontario, M5S 1B2, Canada

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Andrew Kouri, MD

    Womens College Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor Andrew Kouri

Study Record Dates

First Submitted

January 13, 2025

First Posted

June 19, 2025

Study Start

January 15, 2025

Primary Completion

October 1, 2025

Study Completion (Estimated)

June 5, 2026

Last Updated

June 19, 2025

Record last verified: 2025-06

Locations